Legend Biotech (LEGN) Enterprise Value (2019 - 2026)
Legend Biotech's (LEGN) quarterly Enterprise Value came in at -$646.4 million in Q1 2026, up 35.72% YoY from -$476.3 million in Q1 2025, and up 28.33% on a QoQ basis from -$901.9 million in Q4 2025.
Legend Biotech (LEGN) Enterprise Value (2019 - 2026) Analysis & Trends
Legend Biotech (LEGN) has 8 years of Enterprise Value data on file, last reported at -$646.4 million in Q1 2026.
- Quarterly Enterprise Value rose 35.72% year-over-year to -$646.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$646.4 million (up 35.72% YoY) and the FY2025 annual result came in at -$901.9 million, down 214.5% from the prior year.
- Enterprise Value rose to -$646.4 million in Q1 2026, from -$901.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$266.7 million in Q2 2025 to a low of -$1.5 billion in Q2 2023.
- A 5-year average of -$868.1 million and a median of -$901.9 million in 2025 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value surged 77.57% — and 2025, when it tumbled 214.5%.
- Tracing LEGN's Enterprise Value over 5 years: stood at -$971.6 million in 2022, then sank by 31.57% to -$1.3 billion in 2023, then surged by 77.57% to -$286.8 million in 2024, then plunged by 214.5% to -$901.9 million in 2025, then grew by 28.33% to -$646.4 million in 2026.
- The last three Enterprise Value figures came in at -$646.4 million (Q1 2026), -$901.9 million (Q4 2025), and -$278.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | -672.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -672.90 Mn |
| Mar 31, 2026 | -646.40 Mn |
| Dec 31, 2025 | -901.90 Mn |
| Sep 30, 2025 | -278.89 Mn |
| Jun 30, 2025 | -266.66 Mn |
| Mar 31, 2025 | -1.01 Bn |
| Dec 31, 2024 | -286.77 Mn |
| Sep 30, 2024 | -1.07 Bn |
| Jun 30, 2024 | -1.10 Bn |
| Mar 31, 2024 | -1.31 Bn |
| Dec 31, 2023 | -1.28 Bn |
| Sep 30, 2023 | -1.43 Bn |
| Jun 30, 2023 | -1.52 Bn |
| Mar 31, 2023 | -855.77 Mn |
| Dec 31, 2022 | -971.63 Mn |
| Sep 30, 2022 | -871.33 Mn |
| Jun 30, 2022 | -688.98 Mn |
| Mar 31, 2022 | -277.79 Mn |
| Dec 31, 2021 | -638.94 Mn |
| Sep 30, 2021 | -388.37 Mn |